FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely nephrology, dietology, namely to a method for screening protein-energy malnutrition in a patient receiving treatment with programmed hemodialysis. That is ensured by measuring blood serum albumin and taking into account the length of hemodialysis therapy, as well as determining the absolute number of blood serum lymphocytes and by asking the patient to determine the behavior of appetite changes in last 4 weeks, the presence and severity of gastrointestinal symptoms, the nature of motor activity, each index is evaluated in points according to point score system and if total score is more than 5 high risk of PEM is detected.
EFFECT: invention provides high sensitivity and specificity of PEM screening in a patient receiving treatment with program HD, and enables high-effective detection of patients in need of detailed diagnosis of PEM.
1 cl, 1 dwg, 4 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SCREENING SARCOPENIA IN A PATIENT RECEIVING PROGRAMMED HEMODIALYSIS | 2019 |
|
RU2710267C1 |
METHOD FOR DIAGNOSTICS OF PROTEIN-ENERGY INSUFFICIENCY IN ADULT PATIENTS WITH STAGE 3A-5D CHRONIC KIDNEY DISEASE | 2021 |
|
RU2770551C1 |
METHOD FOR PREDICTING SARCOPENIA IN PATIENTS RECEIVING CHRONIC HEMODIALYSIS TREATMENT | 2023 |
|
RU2811653C1 |
METHOD FOR CORRECTION OF PRE-SARCOPENIA OR SARCOPENIA CORRECTION IN A PATIENT WITH ADEQUATE CONSUMPTION OF ESSENTIAL NUTRIENTS RECEIVING PROGRAMMED HEMODIALYSIS | 2018 |
|
RU2686086C1 |
METHOD FOR DETERMINATION OF THE TREATMENT ONSET BY PROGRAM HEMODIALYSIS OF PATIENTS WITH CKD C5 | 2017 |
|
RU2653819C1 |
METHOD FOR DIAGNOSING SARCOPENIA IN PATIENTS WITH STAGE 5 CHRONIC KIDNEY DISEASE RECEIVING TREATMENT WITH LONG-TERM HEMODIALYSIS | 2020 |
|
RU2756154C1 |
METHOD OF PREDICTION OF DEVELOPING SUPPURATIVE COMPLICATIONS OF PANCREATONECROSIS AT EARLY STAGES OF DISEASE | 2015 |
|
RU2605851C1 |
METHOD FOR DETECTING GASTRIC MUCOSA EROSIONS IN CHILDREN WITH JUVENILE ARTHRITIS | 2014 |
|
RU2574031C1 |
METHOD FOR ASSESSING THE EFFECTIVENESS OF THE NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS SUFFERING RECTAL CANCER | 2019 |
|
RU2705257C2 |
METHOD FOR DETECTING AND TREATING PHARYNGOLARYNGEAL REFLUX | 2019 |
|
RU2716486C1 |
Authors
Dates
2019-08-21—Published
2018-09-17—Filed